Clinical Trial: Study on the clinical benefits of achieving serum uric acid levels below 6.0 mg/dL: A Database Approach(Japan)

Tokyo, June 26 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000057910) titled 'Study on the clinical benefits of achieving serum uric acid levels below 6.0 mg/dL: A Database Approach' on May 19

Study Type:

Observational

Study Design:

Primary Sponser:

Institute - MOCHIDA PHARMACEUTICAL CO., LTD.

Condition:

Condition - Gout, hyperuricemia Classification by malignancy - Others Genomic information - NO

Objective:

Intervention:

Eligibility:

Age-lower limit - 18 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - 1. Database registration within the database period. 2. Subjects whose serum uric acid levels are available at least once during the ob...